As suggested by the Drosophila RAS studies, human SIAH-dependent proteolysis might also play a similar role as the most downstream signaling “gatekeeper” identified in the oncogenic K-RAS pathway in pancreatic cancer (Figure 2). This evidence concerns the gene KRAS and familial pancreatic carcinoma.